首页> 外文期刊>Diseases of Aquatic Organisms >Challenge of New Zealand Greenshell™ mussel Perna canaliculus larvae using two Vibrio pathogens: a hatchery study
【24h】

Challenge of New Zealand Greenshell™ mussel Perna canaliculus larvae using two Vibrio pathogens: a hatchery study

机译:利用两种弧菌病原体挑战新西兰Greenshell™贻贝Perna canaliculus幼虫:孵化场研究

获取原文
           

摘要

ABSTRACT: Bacterial diseases remain a large problem in aquaculture hatcheries. The successful design and implementation of protective measures in the hatchery depends on an understanding of the dynamics of the infection process. Developing an in situ experimental protocol for pathogen challenge is therefore of paramount importance. Here, we demonstrated the minimum effective pathogenic dose (MEPD) of Vibrio splendidus (105 CFU ml–1) and a Vibrio coralliilyticuseptunius-like isolate, Vibrio sp. DO1 (106 CFU ml–1), for New Zealand Greenshell™ mussel (GSM, Perna canaliculus) larvae during hatchery production. In a flow-through water hatchery system, larvae given 1 to 2 h of static water exposure to these pathogen doses showed respective average cumulative mortalities of 58 and 69% on the fourth day following pathogen exposure. After the 1 to 2 h static exposure, larvae were returned to flow-through water. Larvae exposed to a dosage one order of magnitude greater than the MEPD had higher mortalities of 73 and 96% for V. splendidus and Vibrio sp. DO1 respectively. These 4 levels of mortality were significantly greater than those of the non-exposed control larvae which respectively averaged 23 and 35% in experiments involving V. splendidus and Vibrio sp. DO1. Experiments were repeated 4 times to confirm reproducibility. After pathogen exposure, pathogens were detected in the larvae and tank water of treatments with dosages of ≥105 CFU ml–1 (V. splendidus) and 106 CFU ml–1 (Vibrio sp. DO1), but not in treatments with lower pathogen dosages. The challenge protocols are reproducible and provide an opportunity to assess measures for the protection of GSM larvae against infection in the hatchery environment.
机译:摘要:细菌疾病仍然是水产养殖孵化场的一个大问题。孵化场中保护措施的成功设计和实施取决于对感染过程动态的了解。因此,开发用于病原体攻击的原位实验方案至关重要。在这里,我们证明了脾脏弧菌(10 5 CFU ml –1 )和弧菌的最小有效致病剂量(MEPD)珊瑚/海马状分离株弧菌 sp。 DO1(10 6 CFU ml –1 ),用于孵化场生产过程中的新西兰Greenshell™贻贝(GSM, Perna canaliculus )幼虫。在流水孵化场系统中,在这些病原体剂量下静置暴露1至2小时的幼虫,在病原体接触后第四天分别显示分别为58%和69%的平均累积死亡率。静态暴露1至2小时后,将幼虫放回流通水中。幼虫暴露于比MEPD大一个数量级的剂量下,对于V而言,其死亡率更高,分别为73%和96%。 splendidus 和 Vibrio sp。 DO1分别。这四个死亡率水平显着高于未暴露的对照幼虫的死亡率,在涉及iV的实验中,它们分别平均为23%和35%。 splendidus 和 Vibrio sp。 DO1。重复实验4次以确认可重复性。暴露于病原体后,在≥10 5 CFU ml –1 ( Spledidus )和10 6 CFU ml –1 ( Vibrio sp。DO1),但不适用于病原体剂量较低的治疗。挑战规程是可重现的,并为评估保护GSM幼虫免受孵化场环境感染的措施提供了机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号